Vedanta, Wipro and Shree Cement to see some action today

Vedanta Ltd. | Metal - Non Ferrous | Metals & Mining | BSE: 500295 | NSE: VEDL

21 Dec 2021 Evaluate

Vedanta has acquired Nicomet, a leading nickel and cobalt producer which is based in Goa. The acquisition is in line with Vedanta's ESG mission and is a big step towards supporting India's carbon neutrality goals. With this acquisition, Vedanta has become the country's sole producer of nickel.

Wipro has signed an agreement to acquire Austin, Texas headquartered Edgile, a transformational cybersecurity consulting provider that focuses on risk and compliance, information and cloud security, and digital identity.

Shree Cement is planning to set up Rs 1500 crore a Greenfield Cement plant at Guntur district in Andhra Pradesh (AP). The company has cement manufacturing and allied sectors plants in nine states and it will be setting up its first plant in Andhra Pradesh and the plan is prepared to complete the project in 24 months.

KPI Global Infrastructure has received order for executing solar power project of 2.50 MW dc capacity from Vineet Polyfab, Surat under 'Captive Power Producer (CPP)' segment of the Company. Earlier, the company has received orders for executing solar power project of 2.78 MWdc capacity from Parag Syntex and Shivram Dyeing & Printing Mill under CPP Segment of the company.

Kalpataru Power Transmission (KPTL) and Techno Electric & Engineering Company (TEECL), a joint venture partner in KMTL, have successfully completed transfer of 49% stake (23% by KPTL and 26% by TEECL) in Kohima?Mariani Transmission (KMTL) to Apraava Energy (formerly known as CLP India). The remaining stake in KMTL will be transferred by KPTL in accordance with the terms of the Transmission Service Agreement (TSA).

Strides Pharma Science’s biotech division -- Stelis Biopharma (Stelis) has commissioned its large-scale fully integrated vaccine manufacturing facility at Bengaluru, India. The facility was successfully inspected by the Central Drugs Standard Control Organization (CDSCO). Stelis has also received an initial Export No Objection Certificate (NOC) from CDSCO to export up to 50 million doses of the Sputnik Light vaccine.

Jubilant Ingrevia has raised Rs 100 crore through Commercial Papers (‘CPs’) on December 17, 2021. Date of maturity of said Commercial Papers will be February 1, 2022. Tenure of the instrument is for 46 days. The company has issued Commercial Papers at 3.85% per annum. The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 150 crore.

Vedanta Share Price

309.50 4.45 (1.46%)

12-Jun-2026 16:59 View Price Chart

Peers

Company Name	CMP
Hindalco	1021.40
Vedanta	309.50
Hindustan Zinc	559.85
Jain Resource Recycl	326.40
CMR Green Tech	252.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.